LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

被引：1
|
作者：
Riedl, M.
Cicardi, M.
Hao, J.
Lu, P.
Li, H.
Manning, M.
Bernstein, J.
Busse, P.
Tachdjian, R.
Gower, R.
Wedner, H.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 05期
关键词：
D O I：
10.1016/j.anai.2019.08.263
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P159
引用
收藏
页码：S30 / S31
页数：3
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [2] Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Long-Term Prophylaxis Use: Interim Results From the HELP Open-Label Extension Study
    Paes, Kim
    Craig, Timothy
    Bernstein, Jonathan
    Longhurst, Hilary
    Aygoren-Pursun, Emel
    Nurse, Christina
    Zuraw, Bruce
    Jacobs, Joshua
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB102 - AB102
  • [3] Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study
    Riedl, Marc A.
    Anderson, John T.
    Cicardi, Marco
    Li, H. Henry
    Lockey, Richard F.
    Longhurst, Hilary
    Maurer, Marcus
    Lu, Peng
    Hao, James
    Banerji, Aleena
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB38 - AB38
  • [4] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Use of Long-Term Prophylaxis: Final Results From the HELP Open-Label Extension Study
    Paes, Kim
    Bernstein, Jonathan
    Longhurst, Hilary
    Aygoren-Pursun, Emel
    Ren, Hong
    Craig, Timothy
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB145 - AB145
  • [6] LONG-TERM LANADELUMAB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE: HELP OPEN-LABEL EXTENSION STUDY INTERIM FINDINGS
    Lumry, W.
    Maurer, M.
    Magerl, M.
    Jain, G.
    Devercelli, G.
    Regnault, A.
    Meunier, J.
    Riedl, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S29 - S29
  • [7] LANADELUMAB EFFICACY AFTER SWITCHING FROM PLACEBO: RESULTS FROM THE HELP AND HELP OPEN-LABEL EXTENSION STUDIES
    Tachdjian, R.
    Anderson, J.
    Busse, P.
    Johnston, D.
    Kiani, S.
    Nurse, C.
    Paes, K.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S38 - S38
  • [8] An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
    Riedl, Marc A.
    Bernstein, Jonathan A.
    Craig, Timothy
    Banerji, Aleena
    Magerl, Markus
    Cicardi, Marco
    Longhurst, Hilary J.
    Shennak, Mustafa M.
    Yang, William H.
    Schranz, Jennifer
    Baptista, Jovanna
    Busse, Paula J.
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2017, 7
  • [9] LANADELUMAB REDUCES HAE ATTACK RATE: INTERIM FINDINGS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Bernstein, J.
    Yang, W.
    Longhurst, H.
    Magerl, M.
    Hebert, J.
    Shennak, M.
    Martinez-Saguer, I.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S37 - S37
  • [10] Long-term prevention of attacks with lanadelumab across subgroups of patients with hereditary angioedema (HAE): final results from the HELP open-label extension study
    Maurer, M.
    Bernstein, J. A.
    Jacobs, J.
    Lumry, W. R.
    Ren, H.
    Soteres, D.
    Yu, M.
    Martinez-Saguer, I
    [J]. ALLERGY, 2021, 76 : 10 - 10
12345